Apamarga in Ayurveda: Properties & Everyday Use

What it is

Apamarga is the Ayurvedic name for Achyranthes aspera Linn. (family Amaranthaceae), also called prickly chaff flower or chirchita (JCDR 2024 review). If you only remember one thing about this plant, make it this: almost nobody in the literature is studying apamarga the plant. They are studying what gets made from it. Apamarga Kshara, an alkaline preparation from the plant's ashes, gets coated onto threads to make Kshara Sutra, used in Ayurvedic para-surgical care of anorectal conditions.

The official definition is precise, and we like precise. The Ayurvedic Pharmacopoeia of India (Part I, Vol. II) says the drug is the dried whole plant of Achyranthes aspera, and records the classical profile: rasa (taste) katu and tikta. Guna tikshna and sara; virya ushna; vipaka katu; and karma including kaphahara, vatahara, medohara, chedana, dipana, pachana, and vamaka (API, Part I, Vol. II: journal PDF mirror). Two of those gunas, tikshna and ushna, come back in the safety section. Remember them.

Classical properties

• Taste (rasa): pungent (Katu), bitter (Tikta)
• Qualities (guna): light (Laghu), sharp (Tikshna)
• Potency (virya): warming (Ushna)
• After digestion (vipaka): pungent (Katu)
• Doshas: traditionally said to settle Kapha and Vata; may increase Pitta

Traditional use

The Charaka Samhita opens the second chapter of Sutra Sthana, the Apamarga Tanduliya Adhyaya, by listing drugs used for shirovirechana (errhine or cleansing therapy of the head), and it starts the list with apamarga seeds. Verses 3 through 5 enumerate roughly 25 substances, prescribed for head diseases, pinasa (rhinitis), ardhavabhedaka (a migraine-type headache), krimi (worm infestation), apasmara (epilepsy), loss of smell, and restoration of consciousness (Charaka Samhita, Sutra Sthana 2). Apamarga also shows up in the Bhavaprakasha, Raja, and Madanapala Nighantus (JCDR 2024 review).

The Pharmacopoeia lists the traditional indications as shula (pain), udara roga, apaci (glandular swellings), arsha (piles), kandu (itching), and medoroga (API, Part I, Vol. II: journal PDF mirror). All of these are traditional descriptions, not clinical proof, and the research is kept in its own section below.

What research has looked at

No large, long-term trials of apamarga exist. What exists is small, short, and mostly about combination or procedural uses rather than the herb alone. Here is all of it.

Herbal mouthwash for gingivitis (randomized controlled non-inferiority trial)

The biggest study in the set. A 2024 randomized, controlled, non-inferiority trial in the Journal of Oral Biology and Craniofacial Research (14(5):522–529) enrolled 108 children with plaque-induced gingivitis, randomized into three groups of 36: an A. aspera plus ajwain (Trachyspermum ammi) herbal mouthwash, 0.2% chlorhexidine, and placebo, used for 21 days (Kumar et al. 2024). Gingival and plaque indices were recorded at baseline, day 7, and day 21, with RT-PCR counts of P. gingivalis and T. forsythia at baseline and day 21. Gingival and plaque scores improved in the herbal group, and both active groups showed significant bacterial-count reductions versus placebo. This is one small trial of a combination product, not evidence that it treats gum disease. Never use it in place of, or alongside, prescribed medicine without your doctor.

The catch: this was a combination product, apamarga plus ajwain, not apamarga alone. One positive kids' mouthwash trial is a real result. It is not a license to claim anything broader, and we won't pretend it is.

Periodontal gel (clinical study)

Thirty patients with chronic periodontitis. Scaling and root planing plus a locally delivered A. aspera gel, compared against scaling and root planing plus placebo gel, with gingival index, bleeding on probing, probing pocket depth, and clinical attachment level recorded at baseline and 3 months (Saini et al., J Indian Soc Periodontol). The authors concluded the gel showed a beneficial effect as a non-surgical local drug-delivery system, reporting no side effects. Small and short. Preliminary, which is all we will grant it.

Fistula-in-ano / Kshara Sutra studies

Most of the clinical apamarga literature lives here, and none of it involves swallowing the herb as a remedy. Kshara Sutra is a clinician-applied medicated thread for Bhagandara (fistula-in-ano). Lobo et al. (AYU 2012;33(1):85–91) compared three thread types in 33 patients, 11 per group: Snuhi Ksheera Sutra, Tilanala Kshara Sutra, and Apamarga Kshara Sutra. As summarized in the JCDR 2024 review, Apamarga Kshara Sutra produced a significant effect in reducing pain, itching, pus discharge, and the size of the fistulous tract (JCDR 2024 review). A 30-patient trial compared Apamarga Kshara Sutra with 7 versus 21 coatings; both groups improved in pain, discharge, burning, and itching, with the 21-coating group showing highly significant improvement across symptoms (JCDR 2024 review). Anagha et al. (JAIMS 2022;7(6):28–34) randomized 30 fistula-in-ano patients to Sarjarasa Apamarga Ksharasutra versus Guggulu Apamarga Ksharasutra. The Sarjarasa variant showed higher efficacy for pain and burning sensation, with no necrosis, stenosis, or anal incontinence reported (Anagha et al., JAIMS 2022).

Our read: small, specialized procedural trials. They say something about a clinician-applied thread. They say nothing about apamarga as a general remedy. We won't let anyone blur that line.

Other small trials

Two more exist. A clinical study of Apamarga-Ksharataila Uttarabasti (medicated-oil instillation) in urethral stricture was compared with the dilatation technique; it is a single small study, preliminary, and not a treatment (Apamarga-Ksharataila Uttarabasti clinical study). A CTRI-registered, randomized, single-blind trial in 50 patients (CTRI/2012/11/003157) evaluated Apamarga Kshara Yoga in two dosage forms, lepa and ointment, for vitiligo (Shvitra) (Apamarga Kshara Yoga vitiligo trial). We list the vitiligo trial here as an existing human study only; no effect is claimed.

Safety notes

Apamarga is classically described as tikshna (sharp) and ushna (heating). We asked you to remember those two gunas, and here is why: they are the classical argument against casual self-use (API, Part I, Vol. II: journal PDF mirror). The 30-patient periodontitis gel trial reported no side effects with local use over three months (Saini et al., J Indian Soc Periodontol). The fistula-in-ano trial comparing two Apamarga Ksharasutra variants reported no necrosis, stenosis, or anal incontinence (Anagha et al., JAIMS 2022).

And the part that needs saying plainly: Kshara is an alkaline ash preparation, and Kshara Sutra therapy is a clinician-performed procedure. Neither is a home remedy. Dedicated long-term safety studies of internal apamarga use are lacking, so the usual cautions apply. Read the disclaimer at the bottom of this page.

FAQs

What is Apamarga Kshara?

An alkaline preparation made from the ashes of the apamarga plant, used in Ayurveda to coat Kshara Sutra threads for para-surgical procedures such as fistula-in-ano care (JCDR 2024 review). Not a home remedy.

Is there clinical evidence for apamarga?

Only small, preliminary trials: an apamarga-ajwain mouthwash tested against chlorhexidine for gingivitis in 108 children, a 30-patient periodontal gel study, and small Kshara Sutra trials for fistula-in-ano. No large or long-term trials were found. Everything beyond that is extrapolation, and we'd treat it as such.

Can Kshara Sutra for fistula-in-ano be done at home?

No. Kshara Sutra therapy is a clinician-applied Ayurvedic surgical procedure, not a home project. Fistula-in-ano needs proper diagnosis and supervised care. Do not attempt this at home.

What dose does the Ayurvedic Pharmacopoeia list?

The monograph lists a crude-drug quantity for preparing a decoction, not a personal recommendation. Swastik does not suggest amounts; check with a qualified Ayurvedic practitioner or your doctor before taking any herb (API, Part I, Vol. II: journal PDF mirror).

Is apamarga safe?

A 30-patient gel trial reported no side effects with local use, and a fistula trial reported no serious procedural complications. But long-term safety data for internal use are lacking. Talk to a qualified practitioner before use. The safety file here is thin, and honest writing admits that.

Sources

The pharmacopoeial text is the Ayurvedic Pharmacopoeia of India, Part I, Volume II, Apamarga (whole plant) monograph. Guna, karma, and uses were taken from the monograph via a journal PDF mirror (jmfacpm.com). The classical shirovirechana listing is the Apamarga Tanduliya Adhyaya, Sutra Sthana Chapter 2 of the Charaka Samhita (Charaka Samhita Online). The narrative overview of Apamarga Kshara in Ayurvedic medicine is the JCDR 2024 review, which also summarizes the Lobo et al. thread-type comparison and the 7-versus-21-coating trial (JCDR). The gingivitis mouthwash study is Kumar et al.'s 2024 randomized controlled non-inferiority trial of the A. aspera-ajwain mouthwash (Journal of Oral Biology and Craniofacial Research 14(5):522–529; DOAJ record). The periodontal gel study is Saini et al.'s clinical study of local A. aspera gel in chronic periodontitis (Journal of the Indian Society of Periodontology; PMCID PMC5767990, PMID 29386800; full text). The Sarjarasa-versus-Guggulu Ksharasutra comparison is Anagha et al.'s 2022 randomized controlled clinical study in fistula-in-ano (Journal of Ayurveda and Integrated Medical Sciences 7(6):28–34, DOI: 10.21760/jaims.7.6.5; article). The urethral-stricture study is the clinical evaluation of Apamarga-Ksharataila Uttarabasti (PMCID PMC3821247; full text). The vitiligo study is the clinical-efficacy evaluation of Apamarga Kshara Yoga in Shvitra (PMCID PMC4784126; CTRI/2012/11/003157; full text).

Disclaimer

This article is for educational purposes only and is not medical advice. Herbal products can interact with medications and are not suitable for everyone. Talk to a qualified healthcare practitioner before use, especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.